RSS Statement

Most of the information found on this website comes from RSS Feeds. It is an automated task that provides the information to you. We try to limit items that are duplicates, but with many feeds this can be difficult. Since the owner of this website also has MS and is legally blind this service was necessary to keep the website running with as much automation as possible. Volunteers help from time to time but many have disabilities themselves. We thank you for visiting us and hope that MSC can be of service to you and your loved ones.

Most Read Website

This site is designed to inform and support those with Multiple Sclerosis. It is not a comprehensive medical guide to the disease. This information is taken from many different resources. The writings on this site are not intended to diagnose nor treat. The ideas and writings seen here are not to be substituted for the medical advice of a practicing physician. Prayer is a wonderful treatment but when God does not heal someone it may be necessary for medical treatment of MS

Also see:

MSC Disclaimer 

EasyBlog - Latest Blogs Module

20 February 2020
February 20, 2020 Philip Morris International (PMI) has taken Vital Strategies to task after the special interest group prevented Moira Gilchrist, one of PMI’s leading scientists, from participating in a forum...
20 February 2020
Multiple Sclerosis - MedPage Today Neurology
LOS ANGELES -- A putative neuroprotective agent failed to improve stroke patients' outcomes when given in conjunction with endovascular thrombectomy in the ESCAPE-NA1 trial, although those not given a thrombolytic did appear to benefit.Nerinetide l...
20 February 2020
Multiple Sclerosis - MedPage Today Neurology
LOS ANGELES -- Longer time at a lower low-density lipoprotein (LDL) target appeared to improve secondary prevention in stroke survivors, an analysis of the Treat Stroke to Target trial showed.Targeting 70 mg/dL reduced composite risk of ischemic st...
20 February 2020
Multiple Sclerosis - MedPage Today Neurology
LOS ANGELES -- An investigational low-power MRI scanner appeared safe and feasible for use at the bedside in a standard neuroscience ICU, researchers reported.The 64-mT portable machine under development by Hyperfine Research required no shielding,...
19 February 2020
Multiple Sclerosis - MedPage Today Neurology
Higher out-of-pocket costs were linked with lower medication adherence among patients with peripheral neuropathy or dementia, an analysis of private insurance claims showed.Among neuropathy patients, a $50 increase in out-of-pocket costs for gabapent...

National MS Society News

22 February 2020

This is a list of all national news for the National MS Society.

Who's Online

We have 507 guests and no members online